These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Angiogenic gene therapy strategies for the treatment of cardiovascular disease. Rasmussen HS; Rasmussen CS; Macko J; Yonehiro G Curr Opin Mol Ther; 2002 Oct; 4(5):476-81. PubMed ID: 12435049 [TBL] [Abstract][Full Text] [Related]
23. Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigs. Nikol S; Engelmann MG; Pelisek J; Fuchs A; Golda A; Shimizu M; Mekkaoui C; Rolland PH Acta Physiol Scand; 2002 Oct; 176(2):151-9. PubMed ID: 12354175 [TBL] [Abstract][Full Text] [Related]
24. Effect of transfection time on the survival of epigastric skin flaps pretreated with adenovirus encoding the VEGF gene. Gurunluoglu R; Ozer K; Skugor B; Lubiatowski P; Carnevale K; Siemionow M Ann Plast Surg; 2002 Aug; 49(2):161-9. PubMed ID: 12187344 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation. Schwarz ER; Speakman MT; Patterson M; Hale SS; Isner JM; Kedes LH; Kloner RA J Am Coll Cardiol; 2000 Apr; 35(5):1323-30. PubMed ID: 10758976 [TBL] [Abstract][Full Text] [Related]
27. Stimulation of angiogenesis by Cyr61 gene: a new therapeutic candidate. Fataccioli V; Abergel V; Wingertsmann L; Neuville P; Spitz E; Adnot S; Calenda V; Teiger E Hum Gene Ther; 2002 Aug; 13(12):1461-70. PubMed ID: 12215267 [TBL] [Abstract][Full Text] [Related]
28. Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis. Lazarous DF; Shou M; Stiber JA; Hodge E; Thirumurti V; Gonçalves L; Unger EF Cardiovasc Res; 1999 Nov; 44(2):294-302. PubMed ID: 10690306 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic myocardial angiogenesis via vascular endothelial growth factor gene therapy: moving on down the road. Patterson C; Runge MS Circulation; 2000 Aug; 102(9):940-2. PubMed ID: 10961953 [No Abstract] [Full Text] [Related]
30. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Widenfalk J; Lipson A; Jubran M; Hofstetter C; Ebendal T; Cao Y; Olson L Neuroscience; 2003; 120(4):951-60. PubMed ID: 12927201 [TBL] [Abstract][Full Text] [Related]
31. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Patel SR; Lee LY; Mack CA; Polce DR; El-Sawy T; Hackett NR; Ilercil A; Jones EC; Hahn RT; Isom OW; Rosengart TK; Crystal RG Hum Gene Ther; 1999 May; 10(8):1331-48. PubMed ID: 10365664 [TBL] [Abstract][Full Text] [Related]
32. Vascular growth factor and gene therapy to induce new vessels in the ischemic myocardium. Therapeutic angiogenesis. Kastrup J; Jørgensen E; Drvota V Scand Cardiovasc J; 2001 Oct; 35(5):291-6. PubMed ID: 11771818 [No Abstract] [Full Text] [Related]
33. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mäkinen K; Manninen H; Hedman M; Matsi P; Mussalo H; Alhava E; Ylä-Herttuala S Mol Ther; 2002 Jul; 6(1):127-33. PubMed ID: 12095313 [TBL] [Abstract][Full Text] [Related]
34. [The latest review of therapeutic angiogenesis using angiogenic growth factors to peripheral arterial diseases]. Aoki M; Ogihara T; Morishita R Nihon Rinsho; 2002 Sep; 60(9):1845-55. PubMed ID: 12233086 [TBL] [Abstract][Full Text] [Related]